Abstract
Current therapy of persistent pulmonary hypertension of the newborn (PPHN) consists of optimal ventilation, hemodynamic support and selective vasodilatation with inhaled nitric oxide (iNO). We present herein a case of PPHN non-responsive to iNO but treated successfully with a combination of iNO and intravenous milrinone, a phosphodiesterase III inhibitor. This case suggests that the drug may be a useful adjunctive treatment in the management of PPHN.
Original language | English |
---|---|
Pages (from-to) | 78-80 |
Number of pages | 3 |
Journal | Turkish Journal of Pediatrics |
Volume | 52 |
Issue number | 1 |
Publication status | Published - Jan 2010 |
Keywords
- Milrinone
- Newborn
- Phosphodiesterase III inhibitor
- Pulmonary hypertension
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health